Glaukos Corporation
Clinical in-use observational trial to evaluate the administration of iDose TR (travoprost intracameral implant) in an office-based surgery setting.
This study is a multicenter, single arm, open-label trial in adult subjects with open-angle glaucoma or ocular hypertension. The objective of the study is to assess the safety profile of iDose TR administration in an office-based surgery setting.
Inclusion Criteria: * Diagnosis of Open angle glaucoma (OAG) or ocular hypertension (OHT) Exclusion Criteria: * Prior administration of iDose TR or administration of an investigational intracameral implant in the study eye * Active ocular infection or inflammation * History of hypersensitivity to travoprost or implant components * Recent ocular surgery * Uncontrolled systemic disease * Any condition preventing safe implantation
Travoprost-releasing implant preloaded in a sterile, single-use inserter.
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.